International Clinical Trial: Study on the Safety and efficacy of CD73+NK Cell subsets (ZJ-S-0106) in the Rehabilitation Treatment of Mild and Moderate Alzheimer's Disease(Multicenter)

Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125767) titled 'Study on the Safety and efficacy of CD73+NK Cell subsets (ZJ-S-0106) in the Rehabilitation Treatment of Mild and Moderate Alzheimer's Disease(Multicenter)' on May 31.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shenzhen Second People's Hospital

Condition: Mild and moderate Alzheimers disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Research group:9;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=320655

Published by HT Digital Content Services with permission...